Article Text
Abstract
Introduction/Background Advancements in endovascular therapies have significantly impacted cerebral aneurysm management in recent years. Recent release of the National Inpatient Sample (NIS) data for 2017 provides the opportunity to explore novel population-based insights into outcomes following surgical clipping vs endovascular embolization of ruptured and unruptured cerebral aneurysms.
Materials and Methods This is an analysis of US National Inpatient Sample of hospitalizations with non-traumatic subarachnoid hemorrhage (SAH) or unruptured cerebral aneurysms from January 1, 2017 to December 31, 2017. Baseline patient demographics, open vs endovascular treatment modalities and the associated hospitalization outcomes were analyzed. Primary outcomes included in-hospital mortality and favorable discharge disposition defined as discharge to home.
Results Among 56,165 hospitalizations with unruptured aneurysms, 13,090 (23.3%) underwent endovascular embolization (median age 59, IQR 51-68; Female 74.9% ) and 4105 (7.3%) had surgical clipping (median age 58, IQR 51-65; Female 74.1%). In-hospital mortality occurred in 1.45% in endovascular vs 1.83% in clipping group (p=0.17), whereas favorable discharge outcome was achieved in 87.5% in endovascular vs 74.8% in clipping group (p<0.001). Median hospital length-of-stay was 1 day (IQR 1-4) in endovascular vs 4 days (IQR 3-8) in clipping group (P<0.001). Significantly more favorable outcomes were achieved with coiling vs clipping in those aged 65 or above with unruptured aneurysms. Among 41,420 hospitalizations with non-traumatic SAH, 6,400 (15.5%) underwent endovascular embolization and 2,185 (5.3%) had surgical clipping. In-hospital mortality occurred in 12.6% in endovascular vs 13.9% in clipping group (p=0.41), and favorable discharge outcome was achieved in 44.8% in endovascular vs 40.1% in clipping group (p=0.1) with SAH. Median length-of-stay was 15 days (IQR 10-22) in endovascular vs 16 days (IQR 11-22) in clipping group (P=0.7) with SAH. Clipping was more frequently utilized in younger population (50 years or younger) with SAH; however, outcomes were more favorable with coiling vs clipping in this subgroup (mortality 7.7% vs 11.8%; p=0.01, respectively).
Conclusion In 2017 in US, about 75% of patients were discharged home after clipping and 90% were discharged home after endovascular treatment of an unruptured cerebral aneurysm. About 1 in 7 patients died following clipping and 1 in 8 following endovascular treatment for aneurysmal SAH. Endovascular therapy remains associated with better in-hospital outcomes, including the younger age population with ruptured or unruptured aneurysms.
Disclosures H. Saber: None. M. Jafari: None. A. Desai: None. N. Kaneko: None. G. Colby: 2; C; Medtronic, Stryker, MicroVention. V. Szeder: None. R. Jahan: 2; C; Medtronic. G. Duckwiler: 2; C; Medtronic. S. Tateshima: 2; C; Medtronic, Stryker, Cerenovus.